264th ENMC International Workshop: Multi-system involvement in spinal muscular atrophy Hoofddorp, the Netherlands, November 19th – 21st 2021

Industry participants; Workshop Participants

doi:10.1016/j.nmd.2022.06.005

264th ENMC International Workshop: Multi-system involvement in spinal muscular atrophy Hoofddorp, the Netherlands, November 19th – 21st 2021

Industry participants, Workshop Participants

Division of Nephrology, Hypertension & Apheresis

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Original language	English
Pages (from-to)	697-705
Number of pages	9
Journal	Neuromuscular Disorders
Volume	32
Issue number	8
DOIs	https://doi.org/10.1016/j.nmd.2022.06.005
State	Published - Aug 2022

Access to Document

10.1016/j.nmd.2022.06.005

Cite this

@article{6673e2dcaf5a4998a707d49928da2b3a,

title = "264th ENMC International Workshop: Multi-system involvement in spinal muscular atrophy Hoofddorp, the Netherlands, November 19th – 21st 2021",

author = "{Industry participants} and {Workshop Participants} and Detering, {Nora Tula} and Alberto Zambon and Niko Hensel and Rashmi Kothary and Kathryn Swoboda and Gillingwater, {Thomas H.} and Giovanni Baranello and Simon Parson and Mariascristina Scoto and Melissa Bowerman and John Vissing and Brunhilde Wirth and Peter Claus and Janbernd Kirschner and Enrico Bertini and Stefania Corti and Lorenzo Maggi and Pol, {Ludo van der} and Ewout Groen and Charlotte Sumner and Eduardo Tizzano and Roy, {Susana Quijano} and Isabelle Desguerre and Nuijs, {Alexander Van} and Lemus, {Mencia De} and Rivka Smit and Mary Schroth and Ben Tichler and Ksenija Gorni and Deepa Chand",

note = "Funding Information: GB has received speaker and consulting fees from Biogen, Novartis Gene Therapies, Inc. (AveXis), and Roche and has worked as principal investigator of SMA studies sponsored by Novartis Gene Therapies, Inc., and Roche. The other organizers do not have conflicts to declare for this specific workshop.We acknowledge especially the staff of the European Neuromuscular Center (ENMC) Alexandra Breukel, Managing Director and Annelies Zittersteijn, Operational Manager. This Workshop was made possible thanks to the financial support of the ENMC and ENMC main sponsors: Association Fran{\c c}aise contre les Myopathies (France), Deutsche Gesellschaft f{\"u}r Muskelkranke (Germany), Muscular Dystrophy Campaign (UK), Muskelsvindfonden (Denmark), Prinses Beatrix Spierfonds (The Netherlands), Schweizerische Stiftung f{\"u}r die Erforschung der Muskelkrankheiten (Switzerland), Telethon Foundation (Italy), Spierziekten Nederland (The Netherlands) and the associated members: Finnish Neuromuscular Association (Finland) and {\"O}sterreichische Muskelforschung (Austria). The ENMC acknowledges the support of MDA USA and SMA Europe. Special thanks to the members of the ENMC Company Forum: Amicus Therapeutics, AveXis, Biogen, CSL Behring, Ionis Pharmaceuticals, PerkinElmer, Roche, Sanofi Genzyme, Sanquin Plasma Products, Santhera Pharmaceuticals, and other involved partner organizations for their support of the ENMC workshops. We thank SMA Europe and Cure SMA for the support provided. We acknowledge GB, PC, TG, ET, LvdP, BW have received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sk{\l}odowska-Curie Actions (MSCA) grant agreement SMABEYOND No 956185. Funding Information: We acknowledge especially the staff of the European Neuromuscular Center (ENMC) Alexandra Breukel, Managing Director and Annelies Zittersteijn, Operational Manager. This Workshop was made possible thanks to the financial support of the ENMC and ENMC main sponsors: Association Fran{\c c}aise contre les Myopathies (France), Deutsche Gesellschaft f{\"u}r Muskelkranke (Germany), Muscular Dystrophy Campaign (UK), Muskelsvindfonden (Denmark), Prinses Beatrix Spierfonds (The Netherlands), Schweizerische Stiftung f{\"u}r die Erforschung der Muskelkrankheiten (Switzerland), Telethon Foundation (Italy), Spierziekten Nederland (The Netherlands) and the associated members: Finnish Neuromuscular Association (Finland) and {\"O}sterreichische Muskelforschung (Austria). The ENMC acknowledges the support of MDA USA and SMA Europe. Special thanks to the members of the ENMC Company Forum: Amicus Therapeutics, AveXis, Biogen, CSL Behring, Ionis Pharmaceuticals, PerkinElmer, Roche, Sanofi Genzyme, Sanquin Plasma Products, Santhera Pharmaceuticals, and other involved partner organizations for their support of the ENMC workshops. We thank SMA Europe and Cure SMA for the support provided. We acknowledge GB, PC, TG, ET, LvdP, BW have received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sk{\l}odowska-Curie Actions (MSCA) grant agreement SMABEYOND No 956185 .",

year = "2022",

month = aug,

doi = "10.1016/j.nmd.2022.06.005",

language = "English",

volume = "32",

pages = "697--705",

journal = "Neuromuscular Disorders",

issn = "0960-8966",

number = "8",

}

TY - JOUR

T1 - 264th ENMC International Workshop

T2 - Multi-system involvement in spinal muscular atrophy Hoofddorp, the Netherlands, November 19th – 21st 2021

AU - Industry participants

AU - Workshop Participants

AU - Detering, Nora Tula

AU - Zambon, Alberto

AU - Hensel, Niko

AU - Kothary, Rashmi

AU - Swoboda, Kathryn

AU - Gillingwater, Thomas H.

AU - Baranello, Giovanni

AU - Parson, Simon

AU - Scoto, Mariascristina

AU - Bowerman, Melissa

AU - Vissing, John

AU - Wirth, Brunhilde

AU - Claus, Peter

AU - Kirschner, Janbernd

AU - Bertini, Enrico

AU - Corti, Stefania

AU - Maggi, Lorenzo

AU - Pol, Ludo van der

AU - Groen, Ewout

AU - Sumner, Charlotte

AU - Tizzano, Eduardo

AU - Roy, Susana Quijano

AU - Desguerre, Isabelle

AU - Nuijs, Alexander Van

AU - Lemus, Mencia De

AU - Smit, Rivka

AU - Schroth, Mary

AU - Tichler, Ben

AU - Gorni, Ksenija

AU - Chand, Deepa

N1 - Funding Information: GB has received speaker and consulting fees from Biogen, Novartis Gene Therapies, Inc. (AveXis), and Roche and has worked as principal investigator of SMA studies sponsored by Novartis Gene Therapies, Inc., and Roche. The other organizers do not have conflicts to declare for this specific workshop.We acknowledge especially the staff of the European Neuromuscular Center (ENMC) Alexandra Breukel, Managing Director and Annelies Zittersteijn, Operational Manager. This Workshop was made possible thanks to the financial support of the ENMC and ENMC main sponsors: Association Française contre les Myopathies (France), Deutsche Gesellschaft für Muskelkranke (Germany), Muscular Dystrophy Campaign (UK), Muskelsvindfonden (Denmark), Prinses Beatrix Spierfonds (The Netherlands), Schweizerische Stiftung für die Erforschung der Muskelkrankheiten (Switzerland), Telethon Foundation (Italy), Spierziekten Nederland (The Netherlands) and the associated members: Finnish Neuromuscular Association (Finland) and Österreichische Muskelforschung (Austria). The ENMC acknowledges the support of MDA USA and SMA Europe. Special thanks to the members of the ENMC Company Forum: Amicus Therapeutics, AveXis, Biogen, CSL Behring, Ionis Pharmaceuticals, PerkinElmer, Roche, Sanofi Genzyme, Sanquin Plasma Products, Santhera Pharmaceuticals, and other involved partner organizations for their support of the ENMC workshops. We thank SMA Europe and Cure SMA for the support provided. We acknowledge GB, PC, TG, ET, LvdP, BW have received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Actions (MSCA) grant agreement SMABEYOND No 956185. Funding Information: We acknowledge especially the staff of the European Neuromuscular Center (ENMC) Alexandra Breukel, Managing Director and Annelies Zittersteijn, Operational Manager. This Workshop was made possible thanks to the financial support of the ENMC and ENMC main sponsors: Association Française contre les Myopathies (France), Deutsche Gesellschaft für Muskelkranke (Germany), Muscular Dystrophy Campaign (UK), Muskelsvindfonden (Denmark), Prinses Beatrix Spierfonds (The Netherlands), Schweizerische Stiftung für die Erforschung der Muskelkrankheiten (Switzerland), Telethon Foundation (Italy), Spierziekten Nederland (The Netherlands) and the associated members: Finnish Neuromuscular Association (Finland) and Österreichische Muskelforschung (Austria). The ENMC acknowledges the support of MDA USA and SMA Europe. Special thanks to the members of the ENMC Company Forum: Amicus Therapeutics, AveXis, Biogen, CSL Behring, Ionis Pharmaceuticals, PerkinElmer, Roche, Sanofi Genzyme, Sanquin Plasma Products, Santhera Pharmaceuticals, and other involved partner organizations for their support of the ENMC workshops. We thank SMA Europe and Cure SMA for the support provided. We acknowledge GB, PC, TG, ET, LvdP, BW have received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Actions (MSCA) grant agreement SMABEYOND No 956185 .

PY - 2022/8

Y1 - 2022/8

UR - http://www.scopus.com/inward/record.url?scp=85133386413&partnerID=8YFLogxK

U2 - 10.1016/j.nmd.2022.06.005

DO - 10.1016/j.nmd.2022.06.005

M3 - Article

C2 - 35794048

AN - SCOPUS:85133386413

SN - 0960-8966

VL - 32

SP - 697

EP - 705

JO - Neuromuscular Disorders

JF - Neuromuscular Disorders

IS - 8

ER -

264th ENMC International Workshop: Multi-system involvement in spinal muscular atrophy Hoofddorp, the Netherlands, November 19th – 21st 2021

Access to Document

Other files and links

Cite this